- The world's first SNRI for first line therapy
- Excellent medical treatment rate for depression with
dual action of Serotonin and Norepinephrine
- Superiority in safety and drug tolerance to TCAs
- Rapid efficacy for antidepressant
- Low potential for drug-drug interaction compared to SSRIs
- Excellent dosing flexibility
- Superior remission rate to SSRIs
- Simple pharmacokinetics
Treatment of depression
- The usual recommended dose is 75mg per day given in
two or three divided doses.
- If after several weeks further clinical improvement
is required, the dose may be increased to 150mg per day
given in two divided doses
- The maximum recommended dose is 375mg per day.
